Identification of
Opportunity/Need |
•
Purpose: identify protein biomarker of severe asthma |
• Purpose: develop novel therapeutic for CD infection/colitis |
|
•
Opportunity to leverage current UTMB assets by incorporating CTSA resources |
•
Basic science research in CD infection identified ‐mechanism of virulence |
|
•
Molecular phenotyping is of considerable
interest in academic asthma community |
• Small molecule inhibitor of toxin defined |
|
• CTSA Help: Opportunity recognition |
•
CDI is important source of morbidity and mortality in USA and globally |
|
• CTSA KRs: CC, Pilot |
• CTSA Help: guidance on MTT creation |
|
|
• CTSA KRs: CC |
Team/Network Establishment |
•
Initiation: Working group in place;
team development embryonic. |
•
Initiation: MTT goals established, and necessary expertise determined |
|
•
Team members with expertise in biostatistics, ethics, and informatics were added. |
•
Expertise in biostatistics, regulatory affairs, ethics, and clinical medicine, and trial design was embedded |
|
• Trainee positioned as project manager |
• Team development had not begun |
|
• Team development coach necessary |
•
CTSA Help: Team development, logistics and scheduling; goal setting; leadership development |
|
•
CTSA Help: Team development, trainees; goal setting; leadership development |
• CTSA KRs: CC, Eth, BS, Reg, ED, NM, Pilot |
|
• CTSA KRs: CC, Eth, BS, ED |
|
Team Orientation |
•
Barriers: Nonoverlapping expertise inhibited communication |
•
Barriers: New team required advice and support in many areas |
|
•
“Method Intuition” seminars to improve cross disciplinary communications |
• TSA resources provided rapid start‐up of the MTT |
|
•
Metrics, benchmarks, milestones |
• Facilitated team development |
|
• CTSA Help: Logistics, scheduling, process |
• Regulatory KR completed submission of a necessary IND |
|
• CTSA KRs: CC, BioIT, T&E, ED, Eth |
• CTSA Help: Logistics, scheduling, |
|
|
• CTSA KRs: CC, Reg |
Collaboration/
Exchange/Engagement |
•
Early outcomes: Two manuscripts published in field of molecular phenotyping |
•
Early Outcomes: Definition of S‐NO in toxin inactivation; Metabolomic analysis initiated as parallel project: identify metabolomic signature of CDI infection |
|
•
Incorporation of visual analytics added important mechanistic insights |
• CTSA Help: Grant administration |
|
• CTSA Help: Edit |
• CTSA KRs: CC, NM, TT |
|
• CTSA KRs: CC, BioIT, BS, |
|